Browsing Tag

GT Biopharma

GT Biopharma Announces Two Poster Presentations at the Society for Immunotherapy of…

Eli Pacheco Oct 6, 2022 0

BRISBANE, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company” or “GTB”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative…

Health

GT Biopharma Affirms Manufacturing Timeline For Lead Investigational Asset GTB-3650

Eli Pacheco Aug 31, 2022 0

GTB-3650’s IND application with the FDA expected by end of first quarter of 2023 BRISBANE, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company” or “GTB”) (NASDAQ:…

Health

GT Biopharma Presents Preclinical Data Demonstrating Second-Generation CD19 Targeting…

Eli Pacheco Jun 11, 2022 0

Ongoing experiments will evaluate the functionality and efficacy of GTB-7550 in vivoFuture studies will also involve assessments of GTB-7550 TriKE efficacy in other hematologic cancers…